TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
BDTX

Black Diamond Therapeutics Inc

Healthcare · Biotechnology

1.90$ -0.5% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Black Diamond Therapeutics Inc (BDTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.6% of the shares are freely tradable; institutional investors hold 78.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 78.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 91.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 15.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 58Mio.

Largest Shareholders

Institutions

Institutions BDTX
Name Stake (%) Shares Change (%) Date
T. Rowe Price Investment Management,Inc. 18.39 10,563,103 -18.4 03/31/2026
NEA Management Company, LLC 7.74 4,448,757 +0.0 03/31/2026
Acadian Asset Management LLC 4.09 2,348,651 +939,360.4 03/31/2026
Vanguard Capital Management, LLC 3.22 1,850,468 +0.0 03/31/2026
Defilade Capital Management, L.P. 2.92 1,674,999 +0.0 06/30/2026
Renaissance Technologies Corp 2.86 1,643,747 +73.1 03/31/2026
Dimensional Fund Advisors, Inc. 2.38 1,365,384 +4.9 06/30/2026

Funds

Funds BDTX
Name Stake (%) Shares Change (%) Date
T. Rowe Price Small-Cap Value 3.62 2,077,092 -2.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.71 1,556,251 +0.0 07/31/2026
T. Rowe Price U.S. SC Value Eq Tr-D 2.36 1,353,578 -0.6 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?